Memphis Pharmaceuticals & Chemical Industries Share Price

Equities

MPCI

EGS38351C010

Pharmaceuticals

End-of-day quote Egyptian Exchange 03:30:00 30/04/2024 am IST 5-day change 1st Jan Change
97.95 EGP +11.23% Intraday chart for Memphis Pharmaceuticals & Chemical Industries +6.32% +56.20%

Financials

Sales 2022 551M 11.51M 960M Sales 2023 664M 13.86M 1.16B Capitalization 174M 3.64M 303M
Net income 2022 74M 1.54M 129M Net income 2023 90M 1.88M 157M EV / Sales 2022 -
Net cash position 2022 79.1M 1.65M 138M Net cash position 2023 130M 2.72M 227M EV / Sales 2023 0.07 x
P/E ratio 2022
1.05 x
P/E ratio 2023
1.93 x
Employees 144
Yield 2022 *
-
Yield 2023
6.46%
Free-Float 30%
More Fundamentals * Assessed data
Dynamic Chart
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2023 CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2023 CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2022 CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2022 CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2021 CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the First Quarter Ended September 30, 2021 CI
Memphis Pharmaceutical and Chemical Industries Announces Board Appointments CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2021 CI
Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Half Year Ended December 31, 2020 CI
Memphis Pharmaceuticals Reports Earnings Results for the First Quarter Ended September 30, 2019 CI
Memphis Pharmaceuticals & Chemical Industries Announces Audited Earnings Results for the Year Ended June 30, 2019 CI
Memphis Pharmaceuticals & Chemical Industries Announces Earnings Results for the Nine Months Ended March 31, 2019 CI
Memphis Pharmaceuticals Reports Earnings Results for the Six Months Ended December 31, 2018 CI
More news
1 day+11.23%
1 week+6.32%
Current month-0.33%
1 month-2.94%
3 months+19.79%
6 months+69.90%
Current year+56.20%
More quotes
1 week
83.60
Extreme 83.6
100.00
1 month
83.60
Extreme 83.6
102.30
Current year
60.00
Extreme 60
139.99
1 year
26.22
Extreme 26.22
139.99
3 years
12.20
Extreme 12.2
139.99
5 years
7.95
Extreme 7.95
139.99
10 years
7.30
Extreme 7.3
139.99
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chief Executive Officer - -
Chairman - -
Director/Board Member - -
More insiders
Date Price Change Volume
02/24/02 95.25 +0.80% 31,804
01/24/01 94.49 -3.53% 60,084
30/24/30 97.95 +11.23% 89,060
29/24/29 88.06 +1.07% 11,837
28/24/28 87.13 -3.89% 7,013

End-of-day quote Egyptian Exchange, April 30, 2024

More quotes
Memphis Pharmaceutical and Chemical Industries S.A.E. specializes in researching, manufacturing and marketing pharmaceutical products. The group's products include effervescent, syrups, ointments, injections, tablets and suppositories.
More about the company